FusionNeoAntigen Logo

Home

Download

Statistics

Examples

Help

Contact

Terms of Use

Center for Computational Systems Medicine
leaf

Fusion Gene and Fusion Protein Summary

leaf

Fusion Amino Acid Sequences (multiple BPs and multiple gene isoforms)

leaf

Fusion Protein Breakpoint Sequences - (for the Screening of the FusionNeoAntigens)

leaf

Potential FusionNeoAntigens in HLA I - (netMHCpan v4.1 + deepHLApan v1.1)

leaf

Potential FusionNeoAntigens in HLA II - (netMHCIIpan v4.1)

leaf

Fusion Breakpoint 14 AA Peptide Structure - (RoseTTAFold)

leaf

Filtering FusionNeoAntigens Through Checking the Interaction with HLAs in 3D - (Glide)

leaf

Vaccine Design for the FusionNeoAntigens (RNA/protein sequences)

leaf

Potential target of CAR-T therapy development

leaf

Information on the samples that have these potential fusion neoantigens

leaf

Fusion Protein Targeting Drugs - (Manual Curation)

leaf

Fusion Protein Related diseases - (Manual Curation)

Fusion Protein:IKZF3-SRCIN1

Fusion Gene and Fusion Protein Summary

check button Fusion gene summary
Fusion partner gene informationFusion gene name: IKZF3-SRCIN1
FusionPDB ID: 39410
FusionGDB2.0 ID: 39410
HgeneTgene
Gene symbol

IKZF3

SRCIN1

Gene ID

22806

80725

Gene nameIKAROS family zinc finger 3SRC kinase signaling inhibitor 1
SynonymsAIO|AIOLOS|ZNFN1A3P140|SNIP
Cytomap

17q12-q21.1

17q12

Type of geneprotein-codingprotein-coding
Descriptionzinc finger protein Aioloszinc finger DNA binding protein Aioloszinc finger protein, subfamily 1A, 3 (Aiolos)SRC kinase signaling inhibitor 1P130Cas-associated proteinSNAP-25-interacting proteinSNAP25-interacting proteinp140Cap
Modification date2020032720200320
UniProtAcc

Q9UKT9

Main function of 5'-partner protein: FUNCTION: Transcription factor that plays an important role in the regulation of lymphocyte differentiation. Plays an essential role in regulation of B-cell differentiation, proliferation and maturation to an effector state. Involved in regulating BCL2 expression and controlling apoptosis in T-cells in an IL2-dependent manner. {ECO:0000269|PubMed:10369681}.
.
Ensembl transtripts involved in fusion geneENST idsENST00000346243, ENST00000346872, 
ENST00000350532, ENST00000351680, 
ENST00000377944, ENST00000377945, 
ENST00000377952, ENST00000377958, 
ENST00000394189, ENST00000439016, 
ENST00000467757, ENST00000439167, 
ENST00000535189, ENST00000583368, 
ENST00000264659, ENST00000398579, 
ENST00000578925, 
Fusion gene scores for assessment (based on all fusion genes of FusionGDB 2.0)* DoF score10 X 9 X 7=63012 X 10 X 6=720
# samples 1111
** MAII scorelog2(11/630*10)=-2.51784830486262
possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs).
DoF>8 and MAII<0
log2(11/720*10)=-2.71049338280502
possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs).
DoF>8 and MAII<0
Fusion gene context

PubMed: IKZF3 [Title/Abstract] AND SRCIN1 [Title/Abstract] AND fusion [Title/Abstract]

Fusion neoantigen context

PubMed: IKZF3 [Title/Abstract] AND SRCIN1 [Title/Abstract] AND neoantigen [Title/Abstract]

Most frequent breakpoint (based on all fusion genes of FusionGDB 2.0)IKZF3(37985640)-SRCIN1(36752382), # samples:2
Anticipated loss of major functional domain due to fusion event.IKZF3-SRCIN1 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF.
IKZF3-SRCIN1 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF.
IKZF3-SRCIN1 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF.
IKZF3-SRCIN1 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF.
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types
** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10)

check button Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez
PartnerGeneGO IDGO termPubMed ID
TgeneSRCIN1

GO:0061098

positive regulation of protein tyrosine kinase activity

17525734

TgeneSRCIN1

GO:0061099

negative regulation of protein tyrosine kinase activity

17525734



check button Four levels of functional features of fusion genes
Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr17:37985640/chr17:36752382)
- FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels.
- How to search
1. Put your fusion gene symbol.
2. Press the tab key until there will be shown the breakpoint information filled.
4. Go down and press 'Search' tab twice.
4. Go down to have the hyperlink of the search result.
5. Click the hyperlink.
6. See the FGviewer result for your fusion gene.
FGviewer

check buttonRetention analysis results of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features, are available here.

check buttonFusion gene breakpoints across IKZF3 (5'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.
all structure

check buttonFusion gene breakpoints across SRCIN1 (3'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.
all structure


Top

Fusion Amino Acid Sequences


check buttonFusion information from ORFfinder translation from full-length transcript sequence from FusionPDB.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandSeq length
(transcript)
BP loci
(transcript)
Predicted start
(transcript)
Predicted stop
(transcript)
Seq length
(amino acids)
ENST00000346872IKZF3chr1737985640-ENST00000264659SRCIN1chr1736735044-70362256237541230
ENST00000346872IKZF3chr1737985640-ENST00000578925SRCIN1chr1736735044-47102256238561264
ENST00000394189IKZF3chr1737985640-ENST00000264659SRCIN1chr1736735044-70362256237541230
ENST00000394189IKZF3chr1737985640-ENST00000578925SRCIN1chr1736735044-47102256238561264
ENST00000377944IKZF3chr1737985640-ENST00000264659SRCIN1chr1736735044-70362256237541230
ENST00000377944IKZF3chr1737985640-ENST00000578925SRCIN1chr1736735044-47102256238561264
ENST00000377945IKZF3chr1737985640-ENST00000264659SRCIN1chr1736735044-70362256237541230
ENST00000377945IKZF3chr1737985640-ENST00000578925SRCIN1chr1736735044-47102256238561264
ENST00000377952IKZF3chr1737985640-ENST00000264659SRCIN1chr1736735044-70362256237541230
ENST00000377952IKZF3chr1737985640-ENST00000578925SRCIN1chr1736735044-47102256238561264
ENST00000377958IKZF3chr1737985640-ENST00000264659SRCIN1chr1736735044-70362256237541230
ENST00000377958IKZF3chr1737985640-ENST00000578925SRCIN1chr1736735044-47102256238561264
ENST00000346243IKZF3chr1737985640-ENST00000264659SRCIN1chr1736735044-6974163036921230
ENST00000346243IKZF3chr1737985640-ENST00000578925SRCIN1chr1736735044-4648163037941264
ENST00000350532IKZF3chr1737985640-ENST00000264659SRCIN1chr1736735044-6974163036921230
ENST00000350532IKZF3chr1737985640-ENST00000578925SRCIN1chr1736735044-4648163037941264
ENST00000351680IKZF3chr1737985640-ENST00000264659SRCIN1chr1736735044-6974163036921230
ENST00000351680IKZF3chr1737985640-ENST00000578925SRCIN1chr1736735044-4648163037941264
ENST00000467757IKZF3chr1737985640-ENST00000264659SRCIN1chr1736735044-6974163036921230
ENST00000467757IKZF3chr1737985640-ENST00000578925SRCIN1chr1736735044-4648163037941264
ENST00000439016IKZF3chr1737985640-ENST00000264659SRCIN1chr1736735044-6975164136931230
ENST00000439016IKZF3chr1737985640-ENST00000578925SRCIN1chr1736735044-4649164137951264

check buttonDeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandNo-coding scoreCoding score
ENST00000346872ENST00000264659IKZF3chr1737985640-SRCIN1chr1736735044-0.0006171430.99938285
ENST00000346872ENST00000578925IKZF3chr1737985640-SRCIN1chr1736735044-0.0038010120.99619895
ENST00000394189ENST00000264659IKZF3chr1737985640-SRCIN1chr1736735044-0.0006171430.99938285
ENST00000394189ENST00000578925IKZF3chr1737985640-SRCIN1chr1736735044-0.0038010120.99619895
ENST00000377944ENST00000264659IKZF3chr1737985640-SRCIN1chr1736735044-0.0006171430.99938285
ENST00000377944ENST00000578925IKZF3chr1737985640-SRCIN1chr1736735044-0.0038010120.99619895
ENST00000377945ENST00000264659IKZF3chr1737985640-SRCIN1chr1736735044-0.0006171430.99938285
ENST00000377945ENST00000578925IKZF3chr1737985640-SRCIN1chr1736735044-0.0038010120.99619895
ENST00000377952ENST00000264659IKZF3chr1737985640-SRCIN1chr1736735044-0.0006171430.99938285
ENST00000377952ENST00000578925IKZF3chr1737985640-SRCIN1chr1736735044-0.0038010120.99619895
ENST00000377958ENST00000264659IKZF3chr1737985640-SRCIN1chr1736735044-0.0006171430.99938285
ENST00000377958ENST00000578925IKZF3chr1737985640-SRCIN1chr1736735044-0.0038010120.99619895
ENST00000346243ENST00000264659IKZF3chr1737985640-SRCIN1chr1736735044-0.0005445880.9994554
ENST00000346243ENST00000578925IKZF3chr1737985640-SRCIN1chr1736735044-0.0032804410.99671954
ENST00000350532ENST00000264659IKZF3chr1737985640-SRCIN1chr1736735044-0.0005445880.9994554
ENST00000350532ENST00000578925IKZF3chr1737985640-SRCIN1chr1736735044-0.0032804410.99671954
ENST00000351680ENST00000264659IKZF3chr1737985640-SRCIN1chr1736735044-0.0005445880.9994554
ENST00000351680ENST00000578925IKZF3chr1737985640-SRCIN1chr1736735044-0.0032804410.99671954
ENST00000467757ENST00000264659IKZF3chr1737985640-SRCIN1chr1736735044-0.0005445880.9994554
ENST00000467757ENST00000578925IKZF3chr1737985640-SRCIN1chr1736735044-0.0032804410.99671954
ENST00000439016ENST00000264659IKZF3chr1737985640-SRCIN1chr1736735044-0.0005462880.9994537
ENST00000439016ENST00000578925IKZF3chr1737985640-SRCIN1chr1736735044-0.0032990040.99670094

check button Predicted full-length fusion amino acid sequences. For individual full-length fusion transcript sequence from FusionPDB, we ran ORFfinder and chose the longest ORF among all the predicted ones.

Get the fusion protein sequences from here.

Fusion protein sequence information is available in the fasta format.
>FusionGDB ID_FusionGDB isoform ID_FGname_Hgene_Hchr_Hbp_Henst_Tgene_Tchr_Tbp_Tenst_length(fusion AA) seq_BP

Top

Fusion Protein Breakpoint Sequences for IKZF3-SRCIN1

check button +/-13 AA sequence from the breakpoints of the fusion protein sequences.
HgeneHchrHbpTgeneTchrTbpLength(fusion protein)BP in fusion proteinPeptide
IKZF3chr1737985640SRCIN1chr173673504416354SGEGPANEDEDIGDPERSSPPMLSAD
IKZF3chr1737985640SRCIN1chr173673504416454SGEGPANEDEDIGDPERSSPPMLSAD
IKZF3chr1737985640SRCIN1chr173673504422554SGEGPANEDEDIGDPERSSPPMLSAD

Top

Potential FusionNeoAntigen Information of IKZF3-SRCIN1 in HLA I

check button Multiple sequence alignments of the potential FusionNeoAntigens per fusion breakpoints. If the MSA is empty, then it means that there were predicted fusion neoantigens in this fusion breakpoint, but those predicted fusion neoantigens were not across the breakpoint, which is not fusion-specific.

check button Potential FusionNeoAntigen Information
* We used NetMHCpan v4.1 (%rank<0.5) and deepHLApan v1.1 (immunogenic score>0.5)
Fusion geneHchrHbpTgeneTchrTbpHLA IFusionNeoAntigen peptideBinding scoreImmunogenic scoreNeoantigen start (at BP 13)Neoantigen end (at BP 13)

Top

Potential FusionNeoAntigen Information of IKZF3-SRCIN1 in HLA II

check button Multiple sequence alignments of the potential FusionNeoAntigens per fusion breakpoints. If the MSA is empty, then it means that there were predicted fusion neoantigens in this fusion breakpoint, but those predicted fusion neoantigens were not across the breakpoint, which is not fusion-specific.

check button Potential FusionNeoAntigen Information
* We used NetMHCIIpan v4.1 (%rank<0.5).
Fusion geneHchrHbpTgeneTchrTbpHLA IIFusionNeoAntigen peptideNeoantigen start (at BP 13)Neoantigen end (at BP 13)

Top

Fusion breakpoint peptide structures of IKZF3-SRCIN1

check button3D structures of the fusion breakpoint peptide of 14AA sequence that have potential fusion neoantigens
* The minimum length of the amino acid sequence in RoseTTAFold is 14AA. Here, we predicted the 14AA fusion protein breakpoint sequence not the fusion neoantigen peptide, which is shorter than 14 AA.

Top

Filtering FusionNeoAntigens Through Checking the Interaction with HLAs in 3D of IKZF3-SRCIN1

check buttonVirtual screening between 25 HLAs (from PDB) and FusionNeoAntigens
* We used Glide to predict the interaction between HLAs and neoantigens.
HLA allelePDB IDFile nameBPseqDocking scoreGlide score

Top

Vaccine Design for the FusionNeoAntigens of IKZF3-SRCIN1

check button mRNA and peptide sequences of FusionNeoAntigens that have potential interaction with HLA-Is.
Fusion geneHchrHbpTchrTbpStart in +/-13AAEnd in +/-13AAFusionNeoAntigen peptide sequenceFusionNeoAntigen RNA sequence

check button mRNA and peptide sequences of FusionNeoAntigens that have potential interaction with HLA-IIs.
Fusion geneHchrHbpTchrTbpStart in +/-13AAEnd in +/-13AAFusionNeoAntigen peptideFusionNEoAntigen RNA sequence

Top

Information of the samples that have these potential fusion neoantigens of IKZF3-SRCIN1

check button These samples were reported as having these fusion breakpoints. For individual breakpoints, we checked the open reading frames considering multiple gene isoforms and chose the in-frame fusion genes only. Then, we made fusion protein sequences and predicted the fusion neoantigens. These fusion-positive samples may have these potential fusion neoantigens.
Cancer typeFusion geneHchrHbpHenstTchrTbpTenstSample

Top

Potential target of CAR-T therapy development for IKZF3-SRCIN1

check button Predicted 3D structure. We used RoseTTAFold.

check buttonRetention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, to provide the retention of the transmembrane domain, we only show the protein feature retention information of those transmembrane features


* Minus value of BPloci means that the break point is located before the CDS.
- In-frame and retained 'Transmembrane'.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenProtein featureProtein feature note

check button Subcellular localization prediction of the transmembrane domain retained fusion proteins
* We used DeepLoc 1.0. The order of the X-axis of the barplot is as follows: Entry_ID, Localization, Type, Nucleus, Cytoplasm, Extracellular, Mitochondrion, Cell_membrane, Endoplasmic_reticulum, Plastid, Golgi.apparatus, Lysosome.Vacuole, Peroxisome. Y-axis is the output score of DeepLoc. Clicking the image will open a new tab with a large image.
HgeneHchrHbpHenstTgeneTchrTbpTenstDeepLoc result

Top

Related Drugs to IKZF3-SRCIN1

check button Drugs used for this fusion-positive patient.
(Manual curation of PubMed, 04-30-2022 + MyCancerGenome)
HgeneTgeneDrugSourcePMID

Top

Related Diseases to IKZF3-SRCIN1

check button Diseases that have this fusion gene.
(Manual curation of PubMed, 04-30-2022 + MyCancerGenome)
HgeneTgeneDiseaseSourcePMID

check button Diseases associated with fusion partners.
(DisGeNet 4.0)
PartnerGeneDisease IDDisease name# pubmedsSource